Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

New Surescripts Data Shows Growing Opportunity to Expand the Role of Pharmacists

Surescripts®, the nation’s leading health information network, released a new data report that highlights the biggest issues facing care providers, pharmacist prescribing trends and opportunities for patient care teams to continue evolving to meet the needs of patients.

Report: Clinician Perspectives & Prescribing Patterns Reveal Opportunities for Care Team Evolution

“Barriers that limit health intelligence sharing between clinicians prevent the benefits of an evolving care team, like greater efficiency and more accessible care for patients, from being fully realized,” said Frank Harvey, Chief Executive Officer of Surescripts. “Policies are evolving at the state level to allow pharmacists to provide care at the top of their education and training. While this is a step in the right direction, a truly comprehensive policy shift is still needed to bring reimbursement and access to patient intelligence sharing in line with how care is being delivered today so that we can continue helping healthcare heal itself.”

Key Highlights:

  • 85% of pharmacists and 76% of other clinicians (including physicians, physician assistants and nurse practitioners) ranked prescription medication costs as the top issue and 85% of pharmacists and 72% of other clinicians ranked burnout as the second biggest issue.
  • Since 2023, a growing number of pharmacists (75%, up from 65% in 2023) and other clinicians (29%, up from 26% in 2023) agree with the statement: "we should allow pharmacists to take on more primary care duties like performing point-of-care testing and diagnostics, managing medications used to treat chronic conditions, and prescribing medications for certain conditions."
  • About one-third of pharmacists feel their current position allows them to offer patients all the care they need (36%).
  • Unlike other clinicians, more than 8 in 10 pharmacists regard connecting pharmacists and other clinicians with centralized clinical information about their patients as a high priority. (85% of pharmacists and 57% of other clinicians).
  • Pharmacists and other clinicians agree that it is somewhat or very difficult to share patient information securely and confidently with other care providers (46% of pharmacists and 31% of other clinicians).
  • The top 100 most active pharmacist e-prescribers were responsible for 561,054 new prescriptions nationwide in 2023. Pharmacists in California, New Mexico, and New York accounted for 52.9% of the total nationwide pharmacist-issued e-prescriptions.

Between 2022 and 2023, Surescripts’ analysis shows that e-prescriptions issued by a pharmacist have increased 13% and the number of pharmacists e-prescribing also increased 28.8% in the same timeframe.

The top 100 pharmacists e-prescribing on the Surescripts network prescribed a variety of medications to treat chronic and acute conditions, most commonly diabetic therapies as well as psychoanaleptics and psycholeptics (two classes of medications prescribed for psychiatric conditions like depression, attention-deficit/hyperactivity disorder, anxiety and bipolar disorder).

“This new data shows that patients are driving demand for pharmacists to provide a broader range of clinical care services closer to home, but they need to be reimbursed for these services and gain access to key patient insights to ensure they can provide better quality, safe and less costly care,” said Shannon Reidt, PharmD, MPH, MS, BCPS, Director Medication Research and Analytics for Surescripts. “Given the primary care provider shortages we are seeing, it’s becoming more critical to advance policies that allow pharmacists to care for patients at the full scope of their education and training – which includes medication management for patients with chronic conditions and provide test-to-treat services for patients for routine illnesses.”

Background:

Surescripts partnered with APCO Insight™ to conduct a survey between April 24 and May 2, 2024, to understand the opinions and attitudes of pharmacists and prescribers (including physicians, physician’s assistants and nurse practitioners) on a variety of topics around the healthcare industry including job priorities and challenges, impressions of the wider industry and views toward expanding pharmacists’ role in patient care. A total of 506 individuals completed the online survey.

Surescripts also interviewed leaders from national and regional payer organizations and analyzed E-Prescribing trends between 2019 and 2023.

About Surescripts

Our purpose is to serve the nation through simpler, trusted health intelligence sharing, in order to increase patient safety, lower costs and ensure quality care. At Surescripts, we align healthcare organizations across the nation and convene the Surescripts Network Alliance® to give healthcare professionals the trusted insights they need to serve patients. Together, we’re making interoperability an everyday reality, making it simpler to choose medications patients can afford and adhere to, and getting specialty medications to patients more efficiently. Visit us at surescripts.com and follow us on LinkedIn.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.